Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming

Type-1 diabetes (T1D) is an autoimmune disease in which insulin-secreting pancreatic beta cells are destroyed by the immune system. An emerging strategy to regenerate beta-cell mass is through transdifferentiation of pancreatic alpha cells to beta cells. We previously reported two small molecules, B...

Full description

Bibliographic Details
Main Authors: Choudhary, Amit, Hu He, Kaihui, Mertins, Philipp, Udeshi, Namrata D., Dancik, Vlado, Fomina-Yadlin, Dina, Kubicek, Stefan, Clemons, Paul A., Schreiber, Stuart L., Wagner, Bridget K., Carr, Steven A
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Language:en_US
Published: Public Library of Science 2014
Online Access:http://hdl.handle.net/1721.1/88043
https://orcid.org/0000-0002-7203-4299
_version_ 1826216115368361984
author Choudhary, Amit
Hu He, Kaihui
Mertins, Philipp
Udeshi, Namrata D.
Dancik, Vlado
Fomina-Yadlin, Dina
Kubicek, Stefan
Clemons, Paul A.
Schreiber, Stuart L.
Wagner, Bridget K.
Carr, Steven A
author2 Koch Institute for Integrative Cancer Research at MIT
author_facet Koch Institute for Integrative Cancer Research at MIT
Choudhary, Amit
Hu He, Kaihui
Mertins, Philipp
Udeshi, Namrata D.
Dancik, Vlado
Fomina-Yadlin, Dina
Kubicek, Stefan
Clemons, Paul A.
Schreiber, Stuart L.
Wagner, Bridget K.
Carr, Steven A
author_sort Choudhary, Amit
collection MIT
description Type-1 diabetes (T1D) is an autoimmune disease in which insulin-secreting pancreatic beta cells are destroyed by the immune system. An emerging strategy to regenerate beta-cell mass is through transdifferentiation of pancreatic alpha cells to beta cells. We previously reported two small molecules, BRD7389 and GW8510, that induce insulin expression in a mouse alpha cell line and provide a glimpse into potential intermediate cell states in beta-cell reprogramming from alpha cells. These small-molecule studies suggested that inhibition of kinases in particular may induce the expression of several beta-cell markers in alpha cells. To identify potential lineage reprogramming protein targets, we compared the transcriptome, proteome, and phosphoproteome of alpha cells, beta cells, and compound-treated alpha cells. Our phosphoproteomic analysis indicated that two kinases, BRSK1 and CAMKK2, exhibit decreased phosphorylation in beta cells compared to alpha cells, and in compound-treated alpha cells compared to DMSO-treated alpha cells. Knock-down of these kinases in alpha cells resulted in expression of key beta-cell markers. These results provide evidence that perturbation of the kinome may be important for lineage reprogramming of alpha cells to beta cells.
first_indexed 2024-09-23T16:42:33Z
format Article
id mit-1721.1/88043
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T16:42:33Z
publishDate 2014
publisher Public Library of Science
record_format dspace
spelling mit-1721.1/880432022-09-29T20:54:59Z Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming Choudhary, Amit Hu He, Kaihui Mertins, Philipp Udeshi, Namrata D. Dancik, Vlado Fomina-Yadlin, Dina Kubicek, Stefan Clemons, Paul A. Schreiber, Stuart L. Wagner, Bridget K. Carr, Steven A Koch Institute for Integrative Cancer Research at MIT Carr, Steven A. Type-1 diabetes (T1D) is an autoimmune disease in which insulin-secreting pancreatic beta cells are destroyed by the immune system. An emerging strategy to regenerate beta-cell mass is through transdifferentiation of pancreatic alpha cells to beta cells. We previously reported two small molecules, BRD7389 and GW8510, that induce insulin expression in a mouse alpha cell line and provide a glimpse into potential intermediate cell states in beta-cell reprogramming from alpha cells. These small-molecule studies suggested that inhibition of kinases in particular may induce the expression of several beta-cell markers in alpha cells. To identify potential lineage reprogramming protein targets, we compared the transcriptome, proteome, and phosphoproteome of alpha cells, beta cells, and compound-treated alpha cells. Our phosphoproteomic analysis indicated that two kinases, BRSK1 and CAMKK2, exhibit decreased phosphorylation in beta cells compared to alpha cells, and in compound-treated alpha cells compared to DMSO-treated alpha cells. Knock-down of these kinases in alpha cells resulted in expression of key beta-cell markers. These results provide evidence that perturbation of the kinome may be important for lineage reprogramming of alpha cells to beta cells. Juvenile Diabetes Research Foundation International (JDRF 17-2008-1030) Juvenile Diabetes Research Foundation International (JDRF 17-2011-260) Harvard University. Society of Fellows 2014-06-20T14:33:14Z 2014-06-20T14:33:14Z 2014-04 Article http://purl.org/eprint/type/JournalArticle 1932-6203 http://hdl.handle.net/1721.1/88043 Choudhary, Amit, Kaihui Hu He, Philipp Mertins, Namrata D. Udeshi, Vlado Dancik, Dina Fomina-Yadlin, Stefan Kubicek, et al. “Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming.” Edited by Amar Abderrahmani. PLoS ONE 9, no. 4 (April 23, 2014): e95194. https://orcid.org/0000-0002-7203-4299 en_US http://dx.doi.org/10.1371/journal.pone.0095194 PLoS ONE Creative Commons Attribution http://creativecommons.org/licenses/by/4.0/ application/pdf Public Library of Science Public Library of Science
spellingShingle Choudhary, Amit
Hu He, Kaihui
Mertins, Philipp
Udeshi, Namrata D.
Dancik, Vlado
Fomina-Yadlin, Dina
Kubicek, Stefan
Clemons, Paul A.
Schreiber, Stuart L.
Wagner, Bridget K.
Carr, Steven A
Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming
title Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming
title_full Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming
title_fullStr Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming
title_full_unstemmed Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming
title_short Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming
title_sort quantitative proteomic comparison of alpha and beta cells to uncover novel targets for lineage reprogramming
url http://hdl.handle.net/1721.1/88043
https://orcid.org/0000-0002-7203-4299
work_keys_str_mv AT choudharyamit quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT huhekaihui quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT mertinsphilipp quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT udeshinamratad quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT dancikvlado quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT fominayadlindina quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT kubicekstefan quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT clemonspaula quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT schreiberstuartl quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT wagnerbridgetk quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming
AT carrstevena quantitativeproteomiccomparisonofalphaandbetacellstouncovernoveltargetsforlineagereprogramming